BioXcel unveils data from Phase 1 study of receptor agonist BXCL501

BioXcel unveils data from Phase 1 study of receptor agonist BXCL501

Published: 17 hours ago By Mateen Dalal

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1....

Kazia to team up with U.S. oncology group for brain cancer drug trial

A multi-centre phase-two study will represent the fourth clinical trial ongoing for Kazia’s GDC-0084 drug candidate Kazia Therapeutics Ltd, an Australian oncology-focused biotechnology company, has recently entered into a partnership....

GSK, Zymeworks expand partnership for bispecific antibody development

GSK anticipates using Zymeworks’ Azymetric technology for developing bispecifics drugs that treat communicable diseases Zymeworks Inc, a clinical-stage biopharmaceutical company, has recently announced that GSK has extended its 2016 ....

Vertex, Kymera join forces for developing protein degradation drugs

Vertex would be paying $70 million in advance to work with Kymera including an equity investment in the company Kymera Therapeutics and Vertex Pharmaceuticals Incorporated (VRTX) have reportedly announced that they are entering into a four....

Roche delays acquiring Spark as regulatory review process continues

Roche, the leading Swiss pharma has pushed back its scheduled acquisition of the gene therapy specialist, Spark Therapeutics for third time in a row, as it waits for the U.S. government to complete regulatory review of the proposed $4.3 bil....

Veeba Foods ventures into child nutrition segment with V-Nourish

Condiments and sauce manufacturer Veeba Foods reportedly ventured into child nutrition segment with a new health beverage, V-Nourish. According to sources close to the matter, V-Nourish is a scientifically designed nutritional supplement f....

Amazon plans job cuts as it deploys machines to pack orders

Amazon is well known for its drive to automate as many segments of its business as possible. The American multinational technology company Amazon Inc. is reportedly planning to deploy machines to automate boxing up customer orders. The com....